98 related articles for article (PubMed ID: 23751876)
1. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
[TBL] [Abstract][Full Text] [Related]
2. Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study.
Li G; Wang H; Zhong J; Bai Y; Chen W; Jiang K; Huang J; Shao Y; Liu J; Gong Y; Zhang J; Sun R; Wei T; Gong R; Zhu J; Lu Z; Li Z; Lei J
Br J Cancer; 2024 Apr; 130(6):925-933. PubMed ID: 38238428
[TBL] [Abstract][Full Text] [Related]
3. Role of Ultrasound and Ultrasound-Based Prediction Model in Differentiating Follicular Thyroid Carcinoma From Follicular Thyroid Adenoma.
Zhang F; Mei F; Chen W; Zhang Y
J Ultrasound Med; 2024 Apr; ():. PubMed ID: 38577871
[TBL] [Abstract][Full Text] [Related]
4. Spatial Transcriptomics in a Case of Follicular Thyroid Carcinoma Reveals Clone-Specific Dysregulation of Genes Regulating Extracellular Matrix in the Invading Front.
Condello V; Paulsson JO; Zedenius J; Näsman A; Juhlin CC
Endocr Pathol; 2024 Jan; ():. PubMed ID: 38280140
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.
Codo P; Weller M; Meister G; Szabo E; Steinle A; Wolter M; Reifenberger G; Roth P
Oncotarget; 2014 Sep; 5(17):7651-62. PubMed ID: 25277195
[TBL] [Abstract][Full Text] [Related]
6. Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review.
Lopez JL; Pérez C; Marquez C; Cabrera P; Perez JM; Ramirez GL; Ordoñez R; Praena-Fernandez JM; Ortiz MJ
Rep Pract Oncol Radiother; 2011 May; 16(5):163-9. PubMed ID: 24376974
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations in thyroid cancer: biological and clinical insights.
Landa I; Cabanillas ME
Nat Rev Endocrinol; 2024 Feb; 20(2):93-110. PubMed ID: 38049644
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Insights of Thyroid Cancer Progression.
Leandro-García LJ; Landa I
Endocrinology; 2023 Aug; 164(9):. PubMed ID: 37503738
[TBL] [Abstract][Full Text] [Related]
9. The role of miR-139-5p in radioiodine-resistant thyroid cancer.
Pecce V; Sponziello M; Verrienti A; Grani G; Abballe L; Bini S; Annunziata S; Perotti G; Salvatori M; Zagaria L; Maggisano V; Russo D; Filetti S; Durante C
J Endocrinol Invest; 2023 Oct; 46(10):2079-2093. PubMed ID: 36933170
[TBL] [Abstract][Full Text] [Related]
10. Osteoglycin: An ECM Factor Regulating Fibrosis and Tumorigenesis.
Nulali J; Zhan M; Zhang K; Tu P; Liu Y; Song H
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421687
[TBL] [Abstract][Full Text] [Related]
11. Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells.
Maggisano V; Capriglione F; Verrienti A; Celano M; Gagliardi A; Bulotta S; Sponziello M; Mio C; Pecce V; Durante C; Damante G; Russo D
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625697
[TBL] [Abstract][Full Text] [Related]
12. Loss of Function SETD2 Mutations in Poorly Differentiated Metastases from Two Hürthle Cell Carcinomas of the Thyroid.
Pecce V; Verrienti A; Abballe L; Carletti R; Grani G; Falcone R; Ramundo V; Durante C; Di Gioia C; Russo D; Filetti S; Sponziello M
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674319
[TBL] [Abstract][Full Text] [Related]
13. Osteoglycin (OGN) reverses epithelial to mesenchymal transition and invasiveness in colorectal cancer via EGFR/Akt pathway.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
J Exp Clin Cancer Res; 2018 Mar; 37(1):41. PubMed ID: 29499765
[TBL] [Abstract][Full Text] [Related]
14. Expression of PAX8 Target Genes in Papillary Thyroid Carcinoma.
Rosignolo F; Sponziello M; Durante C; Puppin C; Mio C; Baldan F; Di Loreto C; Russo D; Filetti S; Damante G
PLoS One; 2016; 11(6):e0156658. PubMed ID: 27249794
[TBL] [Abstract][Full Text] [Related]
15. TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Hu R; Hu F; Xie X; Wang L; Li G; Qiao T; Wang M; Xiao H
Tumour Biol; 2016 Sep; 37(9):12181-12191. PubMed ID: 27225290
[TBL] [Abstract][Full Text] [Related]
16. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.
Park J; Kim WG; Zhao L; Enomoto K; Willingham M; Cheng SY
Oncotarget; 2016 Jun; 7(23):34832-44. PubMed ID: 27145454
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers.
Dima M; Pecce V; Biffoni M; Di Gioia CR; Tallini G; Biffoni M; Rosignolo F; Verrienti A; Sponziello M; Damante G; Russo D; Durante C
Endocrine; 2016 Jul; 53(1):145-56. PubMed ID: 26370117
[TBL] [Abstract][Full Text] [Related]
18. Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression.
Rosignolo F; Maggisano V; Sponziello M; Celano M; Di Gioia CR; D'Agostino M; Giacomelli L; Verrienti A; Dima M; Pecce V; Durante C
J Endocrinol Invest; 2015 Dec; 38(12):1283-9. PubMed ID: 26003825
[TBL] [Abstract][Full Text] [Related]
19. PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.
Sponziello M; Verrienti A; Rosignolo F; De Rose RF; Pecce V; Maggisano V; Durante C; Bulotta S; Damante G; Giacomelli L; Di Gioia CR; Filetti S; Russo D; Celano M
Endocrine; 2015 Nov; 50(2):434-41. PubMed ID: 25837309
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.
Puppin C; Durante C; Sponziello M; Verrienti A; Pecce V; Lavarone E; Baldan F; Campese AF; Boichard A; Lacroix L; Russo D; Filetti S; Damante G
Endocrine; 2014 Nov; 47(2):528-36. PubMed ID: 24569963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
